Cohance Lifesciences schedules analyst and investor meeting

Cohance Lifesciences Limited (formerly Suven Pharmaceuticals Limited) has informed stock exchanges about an upcoming analyst/institutional investor meeting. The company's management will attend a "Citigroup Plant Visit & Roadshow" on November 27, 2025, in Hyderabad. This interaction is categorized as a "Group" meeting.

The company explicitly stated that no unpublished price-sensitive information would be shared during this interaction. The schedule is subject to change due to exigencies on the part of the analyst, institutional investor, or the company.

This intimation is made under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Kundan Kumar Jha, company secretary, compliance officer, and head-legal, signed the announcement on November 24, 2025.